12 Health Care Stocks Moving In Tuesday's After-Market Session

Author: Benzinga Insights | August 01, 2023 05:32pm

Gainers

• Reshape Lifesciences (NASDAQ:RSLS) stock rose 9.8% to $1.56 during Tuesday's after-market session. The market value of their outstanding shares is at $4.5 million.
• MiMedx Group (NASDAQ:MDXG) stock rose 8.44% to $8.6. Trading volume for this security closed at 72.0K, accounting for 8.1% of its average full-day volume over the last 100 days. The company's market cap stands at $994.1 million. The company's, Q2 earnings came out today.
• Omnicell (NASDAQ:OMCL) stock moved upwards by 8.26% to $66.8. The company's market cap stands at $3.0 billion. As per the press release, Q2 earnings came out today.
• NeuBase Therapeutics (NASDAQ:NBSE) shares rose 7.75% to $1.39. The market value of their outstanding shares is at $2.6 million.
• Apollomics (NASDAQ:APLM) shares rose 7.6% to $5.8. The market value of their outstanding shares is at $518.9 million.
• Tiziana Life Sciences (NASDAQ:TLSA) shares rose 6.33% to $0.67. The company's market cap stands at $67.3 million.

Losers

• Nevro (NYSE:NVRO) stock decreased by 12.8% to $21.5 during Tuesday's after-market session. The company's market cap stands at $770.0 million. The company's, Q2 earnings came out today.
• Penumbra (NYSE:PEN) stock fell 9.5% to $270.0. Trading volume for this security closed at 54.8K, accounting for 14.7% of its average full-day volume over the last 100 days. The company's market cap stands at $10.3 billion. The company's, Q2 earnings came out today.
• Adamis Pharmaceuticals (NASDAQ:ADMP) shares declined by 8.78% to $3.64. Adamis Pharmaceuticals's trading volume hit 162.7K shares by close, accounting for 105.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $10.1 million.
• Compass Therapeutics (NASDAQ:CMPX) stock decreased by 7.84% to $2.47. The market value of their outstanding shares is at $312.4 million.
• Meihua Intl Medical Techs (NASDAQ:MHUA) shares fell 7.39% to $3.01. The market value of their outstanding shares is at $72.0 million.
• RVL Pharmaceuticals (NASDAQ:RVLP) stock decreased by 6.93% to $0.42. This security traded at a volume of 64.8K shares come close, making up 74.6% of its average volume over the last 100 days. The company's market cap stands at $41.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADMP APLM CMPX MDXG MHUA NBSE NVRO OMCL PEN RSLS RVLP TLSA